Law ex­perts ar­gue that abor­tion drug with­draw­al would 'un­der­mine' the ap­proval process

More than a dozen food and drug law ex­perts ar­gued on Wednes­day that yank­ing the med­ica­tion abor­tion drug mifepri­s­tone from the mar­ket would “un­der­mine the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.